Catalyst Wire Dossier Catalyst Wire Dossier

DBPR108 tablets

DBPR108 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DBPR108 tablets, covering 2019-10-15 to 2019-10-15. Get the full timeline:

Most recent: Clinical Trial Update: DBPR108 Tablets in Type 2 Diabetes Mellitus Patients [Phase 2]

See pricing